Calendar and upcoming reports
August 22, 2023
Interim report January-June 2023
November 8, 2023
Interim report January-September 2023
Investors
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment
August 22, 2023
Interim report January-June 2023
November 8, 2023
Interim report January-September 2023
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: info@egetis.com
